Basic approaches for the development of immunomodulatory and anti-inflammatory drugs acting on the signaling molecules
Basic approaches for the development of immunomodulatory and anti-inflammatory drugs acting on the signaling molecules
批准号:
16390024
负责人:
KASAHARA Tadashi
金额:
$6.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006
中文摘要
许多信号分子作用于IL-1和tnfa介导的信号传导。我们研究了局灶黏附激酶(FAK)和TNF受体相关因子(TRAF)在细胞因子信号转导和各种细胞凋亡诱导剂诱导的细胞凋亡中的作用。该系统被用于开发几种检测系统,以发现新的免疫调节和抗炎药物。我们的发现如下。1)我们发现FAK-/-小鼠的FAK缺陷MEF比FAK+/-细胞更容易发生TNFa和放线菌素d诱导的细胞凋亡,表明FAK+/-细胞对细胞死亡诱导试剂具有抗凋亡作用。在本研究中,FAK与RIP相关,而RIP在FAK-/-细胞的DISC中被招募(Takahashi et al. 2007)。2)此外,TRAF6-/- mef对TNFa和放线菌素d诱导的细胞死亡更为敏感。在这个系统中,活性氧(ROS)参与了细胞的死亡,因此抗氧化剂BHA恢复了ROS诱导的细胞死亡。因此,TRAF6参与了ROS诱导的细胞凋亡(Ichikawa et al. 2006)。发现上述两种细胞培养体系易于适用于筛选抗氧化试剂,以防止细胞凋亡诱导条件。3)我们发现fak过表达的HL-60对包括TRAIL在内的多种凋亡诱导剂诱导的细胞凋亡具有抗性。相反,fak过表达的HL-60对atra诱导的分化具有抗性。这种情况是由于Rb蛋白的过度磷酸化和随后的c/EBPa失活造成的(Hashimoto et al. 2006)。4)发现甘草酸(Glycyrrhizin, GL)及其相关化合物可调节人肺成纤维细胞中抗炎趋化因子、IL-8和eotaxin-1的产生。特别是,11-deoxo-GL和Hetero-30-OH-GL能有效抑制IL-8和eotaxin-1 (Matsui et al. 2004,2006)。这些衍生物现在被设计用于体内试验研究。5)在人肺成纤维细胞中,各种蛋白酶体抑制剂在TNF和IL-4诱导eotaxin-1和eotaxin-3的作用中存在差异(Rokudai et al. 2006)。本研究可用于筛选作用于各种信号分子的免疫调节剂和抗炎剂。少
英文摘要
Many signaling molecules have been identified which act on the IL-1 and TNFa-mediated signaling. We have studied the role of the focal adhesion kinase (FAK) and TNF receptor-associated factors (TRAF) in the cytokine signaling and apoptosis induced by various apoptosis inducing agents. This system was adopted to develop several assay systems to find new immunomodulatory and anti-inflammatory drugs. Our findings are followings.1) We found that FAK deficient MEF derived from FAK-/-mice is more susceptible to the TNFa and actinomycin D-induced apoptosis than the FAK+/-cells, indicating the anti-apoptotic role against the cell-death inducing reagents. In this study, FAK was associated with RIP, while RIP was recruited in the DISC in the FAK-/-cells (Takahashi et al. 2007).2) In addition, TRAF6-/-MEF is more sensitive to the TNFa and actinomycin-D induced cell death. In this system, reactive oxygen species (ROS) was involved in the cell-death and therefore, antioxidant reagent, BHA restored … More ROS-induced cell death. Thus, TRAF6 was involved in the ROS induced apoptosis (Ichikawa et al. 2006).Above two cell-culture systems are found to be easily applicable to the screening antioxidant reagents which protects from apoptosis-inducing conditions.3) We found that FAK-overexpressed HL-60 is resistant against apoptosis induced by the various apoptosis-inducing agents including TRAIL. In contrast, FAK-overexpressed HL-60 is reftractory to the ATRA-induced differentiation. This refactoctory condition was resulted from the hyperphosphorylation of Rb protein and subsequent the c/EBPa inactivation (Hashimoto et al. 2006).4) Glycyrrhizin (GL) and related compounds were found to regulate production of anti-inflammatory chemokines, IL-8 and eotaxin-1 in the human lung fibroblasts. In particularly, 11-deoxo-GL and Hetero-30-OH-GL were effective to inhibit IL-8 and eotaxin-1 (Matsui et al. 2004, 2006). These derivatives are now designed to be studied in in vivo assay.5) Various proteasome inhibitors were found to act differentially in the induction of eotaxin-1 and eotaxin-3 by the TNF and IL-4 in the human lung fibroblast (Rokudai et al. 2006).These study was applicable to the screening of the immunomodulatory and anti-inflammatory agents acting on the various signaling molecules. Less
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.intimp.2004.07.023
发表时间:
2004-12-15
期刊:
International immunopharmacology
影响因子:
5.6
作者:
[Matsui S, Matsumoto H, Sonoda Y, Ando K, Aizu-Yokota E, Sato T, Kasahara T]
通讯作者:
Kasahara T
Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-□ and IL-4 stimulated Human Lung Fibroblast
TNF-□和IL-4刺激的人肺成纤维细胞对Eotaxin-1/CCL11和Eotaxin-3/CCL26产生的差异调节
DOI:
--
发表时间:
2006
期刊:
Biol Pharm Bull 29(6)
影响因子:
--
作者:
[Rokudai R, Terui Y, Kuniyoshi R, Mishima Y, Mishima Y, Aizu-Yokota E, Sonoda Y, Kasahara T, Hatake K]
通讯作者:
Hatake K
Indirubin, a Chinese antileukemia drug, enhances the neutrophilic differentiation of human promyelocyte HL-60 cells.
靛玉红是一种中国抗白血病药物,可增强人早幼粒细胞 HL-60 细胞的中性粒细胞分化。
DOI:
--
发表时间:
2005
期刊:
Brit J Haematol. 130
影响因子:
--
作者:
[Suzuki K, Adachi R, Hirayama A, Watanabe H, Otani S, Watanabe Y, Kasahara T]
通讯作者:
Kasahara T
TGN1412事件とは何か?「TGN1412事件と今後の課題」
TGN1412事件是什么?“TGN1412事件和未来的挑战”
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[山崎恒義, 笠原 忠]
通讯作者:
笠原 忠
予防医学事典;(炎症・免疫、アレルギー、ワクチン 4.炎症)(松島綱治ら編)
预防医学百科全书;(炎症/免疫、过敏、疫苗4.炎症)(由Tsunaharu Matsushima等人编辑)
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[山崎恒義, 笠原 忠, 笠原 忠]
通讯作者:
笠原 忠
共 26 条
Investigation of JAK/STAT signalling and development of new reagents regulating JAK/STAT pathways
-
批准号:24590091
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:KASAHARA Tadashi
-
依托单位:
Investigation of abnormal cytokine signaling and the development of the drugs modulating these signaling
-
批准号:21590072
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:KASAHARA Tadashi
-
依托单位:
Role of TNF receptor-related factor 6(TRAF6) in the apoptosis induction and cytokine receptor signaling
-
批准号:19590075
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:KASAHARA Tadashi
-
依托单位:
STUDY ON THE NEW ANTI-APOPTOTIC MOLECULES ANALYZED BY THE DNA MICROARRAY METHODS
-
批准号:14572066
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:KASAHARA Tadashi
-
依托单位:
Role of Anti-Apoptic Aaction of Focal Adhesion Kinase (FAK)
-
批准号:12672118
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:KASAHARA Tadashi
-
依托单位:
Expression and Regulation of Inflammatory Cytokine Genes In Vitro and In Vivo
-
批准号:04671366
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1992
-
负责人:KASAHARA Tadashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
苏木酮A介导NLRX1调控TRAF6/NF-κB抑制破骨细胞分化缓解骨质疏松症的机制研究
-
批准号:2026JJ82705
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘中
-
依托单位:
牡荆苷通过调控TRAF6介导的巨噬细胞极化缓解脓毒症肠道损伤的机制研究
-
批准号:2026JJ82118
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:易峰
-
依托单位:
NEDD4泛素化调控TLR4/TRAF6/Beclin 1轴介导巨噬细胞极化改善支气管结核的机制研究
-
批准号:2026JJ81722
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗莉
-
依托单位:
黄连纳米囊泡miR-5110靶向TRAF6抑制NLRP3介导的焦亡缓解结肠炎的机制研究
-
批准号:JCZRQNB202600068
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向炎症-骨双靶向策略递送丹参酚酸B
激活DDIT4/TRAF6/P65/Caspase-8信号轴
诱导滑膜细胞凋亡治疗RA的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:刘衍志
-
依托单位:
TRAF6/IRF5通过介导小胶质细胞胞葬作用调控AD神经炎症的功能与机制研究
-
批准号:QN25H090041
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:樊子琦
-
依托单位:
PPAR α调控TRAF6介导的YAP泛素化促进
肝再生的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:范仕成
-
依托单位:
ZC3H13通过TRAF6 m6A修饰促进食管早癌进展及免疫逃逸的机制研究及基于RNA甲基化预测食管早癌内镜治愈性切除模型建立
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘歆阳
-
依托单位:
C5a/C5aR1/SphK1/TRAF6信号轴通过调控STAT3泛素化降解诱导铁死亡促进脓毒症肺损伤的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:戚芹瑶
-
依托单位:
USP17L2调控SphK1/TRAF6/ULK1信号轴参与肺炎支原体肺炎肺泡巨噬细胞自噬和焦亡的发生
-
批准号:2025JJ80639
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘恋红
-
依托单位: